Posts in tag

eye health


Debbie Rigby takes a look at the latest in research news Integration of non-dispensing pharmacists into primary healthcare services This umbrella review and narrative synthesis suggest that the integration of …

Debbie Rigby takes a look at the latest in research news relevant to pharmacy Current and new pharmacotherapeutic approaches for glaucoma Glaucoma is the leading cause of irreversible blindness. This …

Despite previously warning its pharmacist members about an error with atropine eye drops, PDL says it continues to receive incident reports about the problem In its latest practice alert for …

Debbie Rigby rounds up the latest in research news  Adverse health effects and harms related to marijuana use This overview review explores the harms associated with marijuana use. Harm was …

Marijuana use, IBS, dry eye disease, T2 diabetes… Debbie Rigby rounds up the latest in research news Adverse health effects and harms related to marijuana use This overview review explores …

It’s been a busy week in the pharmacy sector, with new information on drug trends, a number of health awareness days and another shot in the turf war There was …

Health professionals have been advised to exercise extreme caution if considering off-label prescribing and supply of atropine eye drops, following the death of an adult patient The TGA has advised …

PDL has warned pharmacists to pay careful attention when dispensing scripts for Atropine eye drops The organisation has received a number of incident reports featuring prescriptions for Atropine 0.01% eye …

Several patient stakeholder groups have made submissions to the Queensland pharmacy inquiry—and none support ownership deregulation Instead, there is significant support for the current ownership model, as well as an …

Debbie Rigby rounds up the latest in research news  Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol The pharmacological treatment for stable COPD …

Debbie Rigby takes a look at the latest in research news Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions Analysis of US Medicaid data shows black, Asian …

A biodegradable implant to help with eye disease has been added to the PBS, for patients who are intolerant or resistant to systemic corticosteroids Ozurdex (dexamethasone 700µg) sustained-release intravitreal implant …